Katie J Simmons (Katie Simmons)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 5

Top Topics

Combination Therapy

Antimicrobial Resistance

Silver Nanoparticles

Microbial Community

Top Venues

International journal of molecular sciences

Circulation research

RSC medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Rute G Matos, Katie J Simmons, Colin W G Fishwick, Kenneth J McDowall, Cecilia Maria Arraiano
Identification of Ribonuclease Inhibitors for the Control of Pathogenic Bacteria. International journal of molecular sciences 25 (15) (2024)
Rute G Matos, Katie J Simmons, Colin W G Fishwick, Kenneth J McDowall, Cecilia Maria Arraiano
Identification of Ribonuclease Inhibitors for the Control of Pathogenic Bacteria. International journal of molecular sciences 25 (15) (2024)
Samuel J Turvey, Martin J McPhillie, Mark T Kearney, Stephen P Muench, Katie J Simmons, Colin W G Fishwick
Recent developments in the structural characterisation of the IR and IGF1R: implications for the design of IR-IGF1R hybrid receptor modulators. RSC medicinal chemistry 13 (4) (2022)
Hema Viswambharan, Nadira Y Yuldasheva, Helen Imrie, Katherine Bridge, Natalie J Haywood, Anna Skromna, Karen E Hemmings, Emily R Clark, V Kate Gatenby, Paul Cordell, Katie J Simmons, Natallia Makava, Yilizila Abudushalamu, Naima Endesh, Jane Brown, Andrew M N Walker, Simon T Futers, Karen E Porter, Richard M Cubbon, Khalid Naseem, Ajay M Shah, David J Beech, Stephen B Wheatcroft, Mark T Kearney, Piruthivi Sukumar
Novel Paracrine Action of Endothelium Enhances Glucose Uptake in Muscle and Fat. Circulation research 129 (7) (2021)
Claire Scott, Jayakanth Kankanala, Toshana L Foster, Daniel H Goldhill, Peng Bao, Katie J Simmons, Marieke Pingen, Matthew Bentham, Elizabeth Atkins, Eleni-Anna Loundras, Ruth Elderfield, Jolyon K Claridge, Joseph Thompson, Peter R Stilwell, Ranjitha Tathineni, Clive S McKimmie, Paul Targett-Adams, Jason R Schnell, Graham P Cook, Stephen Evans, Wendy S Barclay, Richard Foster, Stephen D Griffin
Site-directed M2 proton channel inhibitors enable synergistic combination therapy for rimantadine-resistant pandemic influenza. PLoS pathogens 16 (8) (2020)